96117 ⎘
POTENT NON-UREA INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE
#2Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#3Hydrophilic fentanyl derivatives
#4Antiproliferative compounds, and their pharmaceutical compositions and uses
#5Cyclopropylamines as LSD1 inhibitors
#6Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#7Antiproliferative compounds, and their pharmaceutical compositions and uses
#8Sulfur derivatives as chemokine receptor modulators
#9Anthracene-9, 10-dione dioxime compound prodrugs and their uses
#10Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
#11Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds
#12Cyclopropylamines as LSD1 inhibitors
#13Methods of forming ciclopirox or derivatives thereof in a subject by administration of prodrug
#14Potent non-urea inhibitors of soluble epoxide hydrolase
#15Polymer nanoparticles
#16Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
#17Catalytic enantioselective synthesis of 2-aryl chromenes and related phosphoramidite ligands and catalyst compounds
#18Methylphenidate-prodrugs, processes of making and using the same
#19Alkylated imino sugars exhibiting glucosidase inhibition and their method of use
#20Method of treatment with prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin in-2-1H-one and derivatives thereof
#21Fluorine-containing phosphate ester-amide, and flame retardant resin, flame retardant liquid and flame retardant solvent for organic synthesis containing same
#22Cyclopropylamines as LSD1 inhibitors
#23Potent non-urea inhibitors of soluble epdxide hydrolase
#24Dialkyl(2-alkoxy-6-aminophenyl)phosphine, the preparation method and use thereof
#25Methylphenidate-oxoacid conjugates, processes of making and using the same
#26Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
#27Sulfur derivatives as chemokine receptor modulators
#28Cyclopropylamines as LSD1 inhibitors
#29Large pore metal organic frameworks
#30PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
#31Sulfur derivatives as chemokine receptor modulators
#32Polymer nanoparticles